Shanghai Yizhong Pharmaceutical Company Description

Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the research and development of anti-tumor drugs and related products in China.

The company offers paclitaxel polymer micelles for injection for the treatment of non-small cell lung cancer, as well as various types of cancer, including esophageal cancer, gastric cancer, nasopharyngeal carcinoma, pancreatic cancer, breast cancer, and gynecological tumors.

Shanghai Yizhong Pharmaceutical Co., Ltd. was founded in 2009 and is headquartered in Shanghai, China.

Shanghai Yizhong Pharmaceutical Co., Ltd.

Country	China
Founded	2009
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	437
CEO	Jingsong Zhou

Contact Details

Address: No.79 Renqi Road Shanghai, 201401 China
Phone	86 21 3719 0005
Website	yizhongpharma.com

Stock Details

Ticker Symbol	688091
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000050F4
SIC Code	2834

Key Executives

Name	Position
Jingsong Zhou	Chairman and GM